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Type 1 diabetes (T1D) is an increasingly common chronic illness in children and 
adolescents that can result in short- and long-term health complications. Adolescents with 
T1D represent a uniquely vulnerable population, as both physical and psychological 
disease outcomes tend to deteriorate during this period of development. Thus, among 
adolescents it is crucial to gain further understanding of what psychological and 
contextual factors promote optimal disease management. While traditional methods of 
assessment in this population involve one-time, long-term measurements of psychosocial 
factors and glycemic control, ecological momentary assessment (EMA), including daily 
diaries, are increasingly used to capture change processes both between and within 
individuals. The present study utilized EMA methods (daily diaries for seven days) to 
explore associations between general stress (GS), diabetes-specific stress (DSS), and 
glycemic control. Anxiety was measured at baseline and examined as a moderator.  
Forty-four adolescents (ages 13-17) diagnosed with T1D were recruited from 
diabetes summer camps. Participants completed the Revised Children’s Manifest Anxiety 
Scale, 2nd Edition at camp. Daily diaries, including measures of GS and DSS, were 
completed in the fall. Participants uploaded blood glucose values via Tidepool®, which 
were used to calculate daily mean blood glucose values. Daily GS and DSS scores were 
used to quantify both within- and between-subjects variance in each construct. 
Multilevel model analyses revealed that increased within-subjects fluctuations in 
daily DSS were predictive of poorer daily glycemic control. Conversely, between-
subjects variation in average levels of DSS across the measurement period did not play a 
significant role in predicting mean daily blood glucose. GS levels were not predictive of 
glycemic control at either level. Additionally, trait anxiety did not moderate the 
association of fluctuations in daily DSS with glycemic control.  
Overall, the association between fluctuations in daily diabetes-specific stress and 
same-day glycemic control highlights the need for clinicians to focus on bolstering 
adolescents’ adaptive responses to daily disease-related stressors. Additionally, this study 
underscores the importance of examining both between- and within-person psychosocial 
processes in individuals with T1D in order to fully understand the mechanisms 
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Type 1 diabetes (T1D) is one of the most prevalent chronic illnesses in the United 
States. Currently, 1.25 million individuals are living with T1D, including an estimated 
200,000 children and adolescents (Centers for Disease Control and Prevention, 2017). 
With up to 18,000 new cases in youth annually, it is expected that by the year 2050 up to 
600,000 children and adolescents will be living with the disease (Dabelea et al., 2014). 
An autoimmune disease, T1D results when pancreatic cell destruction leads to insulin 
deficiency, resulting in an inability to convert food and glucose into energy (Daneman, 
2006). Because T1D is most often diagnosed in childhood or young adulthood, the 
disease poses many inherent challenges to youth and their caregivers, including constant 
disease monitoring and an often invasive treatment regimen. Poor disease management 
may have serious short- and long-term consequences for physical health. Adolescents 
represent a uniquely vulnerable population, as both physical and psychological disease 
outcomes tend to deteriorate during this period of development (Garvey et al., 2012; 
Hilliard et al., 2013). Additionally, adolescence is often the time when youth begin to 
assume more responsibility for their own disease management, and they form habits that 
are likely to carry into adulthood. Thus, among adolescents it is crucial to gain further 
understanding of what psychological and contextual factors promote optimal disease 
management.  
There are many psychological factors whose associations with disease 
management and glycemic control are well established in pediatric diabetes literature. 
The emotional burden of living with and managing a chronic illness daily may lead to 
internalizing symptoms, particularly depression. A wealth of existing research shows 
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higher levels of psychological distress in adolescents with T1D when compared to their 
healthy peers; additionally, increases in depressive symptoms are linked with poorer 
glycemic control in teens with T1D (Buchberger et al., 2016; Hood et al., 2006). A meta-
analysis of studies examining psychological distress among children and adolescents with 
T1D as compared to their healthy peers revealed that those with T1D report significantly 
higher levels of depressive symptoms, a higher frequency of clinical depression, more 
anxiety, and more general psychological distress than the control group (Reynolds & 
Helgeson, 2011). Health-related quality of life is poorer for youth with T1D, and it also 
tends to deteriorate in adolescence (Graue et al., 2003). Stress may also negatively affect 
adolescents’ ability to manage their disease. In addition to the general stress experienced 
by healthy adolescents, youth with T1D experience diabetes-specific stressors that are 
related to poor glycemic control (Helgeson et al., 2010). Optimal glycemic control 
requires adolescents (and their caregivers) to adhere to a strict health regimen and to 
successfully carry out a variety of regulatory tasks every day, which can cause stress 
specifically related to completing out these tasks.  
Historically, the study of psychosocial factors in the context of pediatric diabetes 
has relied on one-time recall measurements. This approach, while logistically simple, 
conflicts somewhat with psychologists’ interest in youths’ everyday, real-world behavior. 
Ecological momentary assessment (EMA) refers to a range of assessment methods that 
are naturalistic, ambulatory, and real-time (Heron et al., 2017). These methods have 
many methodological advantages, including reduced recall errors and bias and increased 
ecological validity (Smyth & Heron, 2014). EMA is particularly relevant to research 
examining glycemic control and related factors in children and adolescents with T1D 
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given the potential for daily fluctuations in individual characteristics and diabetes 
management demands.  
The present study will utilize EMA methods to examine relationships between 
daily stress and daily blood glucose levels and the potential moderating role of anxiety. 
Following a summary of basic information about T1D in adolescents, literature pertaining 
to anxiety and stress in this population will be reviewed. The paper will then describe 
existing research employing EMA methods with youth with T1D before discussing the 
goals and approach of the present study.  
The following terms will be used throughout this paper and must therefore be 
defined. “Glycemic control” refers to typical levels of blood glucose in an individual and 
is often used as a proxy for how well-controlled one’s diabetes is. “Adherence” or 
“treatment adherence,” sometimes also referred to as “compliance,” will be used to 
describe the degree to which youth follow typical medical advice for the management of 
T1D (American Diabetes Association, 2020). Although the terms are sometimes 
conflated in T1D research, it is important to note that “adherence” is a behavioral 
construct while “glycemic control” refers to the physiological outcome.  In this study, 
glycemic control will be utilized as an objective physiological indicator of disease 
management, with lower values corresponding to more successful management.  
Type 1 Diabetes Management 
For youth and adults with T1D, disease management involves an intensive 
treatment regimen that often requires individuals to fit their lifestyle to their illness. To 
compensate for the fact that the pancreas does not produce insulin, individuals with T1D 
must monitor their blood glucose (BG) levels and administer insulin appropriately. 
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Medical professionals encourage individuals with T1D to aim for BG levels similar to 
those of healthy individuals. Glycemic control reflects the extent to which individuals 
accomplish this, with lower numbers reflecting better control. Target BG levels for 
children and adolescents vary slightly by age but generally range from 90 to 150 mg/dl 
(American Diabetes Association, 2020). BG levels have traditionally been monitored 
with multiple daily finger pricks. Continuous glucose monitors (CGMs), introduced in 
2005, provide a glucose level once every five minutes, resulting in infinitely more data 
than one receives from finger prick checks four to six times per day. The use of CGMs in 
adolescents with T1D can significantly improve their glycemic control by providing 
accurate data, promoting patient communication with medical providers, and enhancing 
motivation to self-monitor blood glucose levels (Bergenstal et al., 2010; Schaepelynck-
Belicar et al., 2003). Recent data from the Type 1 Diabetes Exchange Registry suggest 
that 17% of adolescents nationwide use a CGM, a number that increased significantly 
between 2011 and 2016 (DeSalvo et al., 2018). Current recommendations include 
considering CGM use for all children and adolescents with T1D (American Diabetes 
Association, 2020). 
 Long-term glycemic control is measured with hemoglobin A1C (HbA1C), which is 
an objective measure reflecting one’s average BG level over the past two to three months 
(Gonder-Frederick & Cox, 1991). Values are expressed as percentages of hemoglobin 
that is glycated (i.e., bonded to glucose). Recommendations from the American Diabetes 
Association for target HbA1C levels are presented by age group, such that adolescents are 
expected to meet similar requirements to adults (American Diabetes Association, 2020). 
Achieving lower HbA1C levels, while ideal, also creates more frequent risk for 
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hypoglycemia. Young children may also be less able to recognize physiological 
symptoms of hypoglycemia; hence, children under 6 years of age have a target HbA1C 
value of 7.5% to 8.0%. Adolescents are told to aim for a value under 7.5% given the 
higher risk of poor glycemic control leading to complications post-puberty.   
Physiological Complications of T1D 
 Poor glycemic control can have severe short- and long-term consequences for 
individuals with T1D. Without (and sometimes even with) close daily attention to BG 
levels and insulin administration, inconsistent out-of-range BG levels can lead to short-
term physiological symptoms and above-target HbA1C levels in the long term. In the 
moment, low BG levels can cause immediate symptoms including shakiness, sweating, 
irritability, confusion, rapid heartbeat, dizziness, hunger, and weakness (American 
Diabetes Association, 2020). High BG levels can lead to thirst, frequent urination, 
headaches, nausea, and diabetic ketoacidosis, which is a life-threatening condition in 
which the body breaks down fat and muscle for energy due to a lack of available insulin 
(Wolfsdorf et al., 2006). Long-term complications of T1D typically result from 
chronically high BG levels, as symptoms of hyperglycemia are easier to ignore or 
habituate to. Immediate symptoms of low BG are disruptive and often incapacitating; 
thus, hypoglycemia is often treated immediately. That said, extremely low BG levels can 
result in seizures and loss of consciousness, especially in children and other individuals 
unable to recognize early symptoms of hypoglycemia. T1D reduces the typical lifespan 
by 11 to 13 years and significantly increases the risk of heart disease and stroke 
(Livingstone et al., 2015). Kidney damage is a common long-term complication and leads 
to complete kidney failure over time in approximately 30% of patients with T1D 
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(National Kidney Foundation, 2015). Neuropathy in the feet and other extremities is also 
common. T1D is the leading cause of both blindness and lower limb amputations in the 
U.S. every year (American Diabetes Association, 2020).  
T1D in Adolescence 
 In addition to the many inherent management challenges of T1D at any age, 
adolescents must also grapple with developmental challenges that occur during this 
period. Adolescence is a pivotal time for T1D management, especially as caregiver 
involvement tends to decrease and adolescents take on increasing responsibility (Hanna 
& Guthrie, 2003). Adolescence is a period of rapid biological development and 
increasing emotional, cognitive, and physical maturity that is often characterized by 
teens’ search for autonomy and independence from caregivers (Herzer & Hood, 2010). 
Moreover, hormonal development can trigger changes in insulin sensitivity related to 
physical growth and sexual maturation and may also result in a neurological vulnerability 
to hypoglycemia and hyperglycemia (Barnea-Goraly et al., 2014). More than half of 
youth with T1D do not meet the glycemic control guidelines prescribed by their 
endocrinologists (Amed et al., 2013). A wealth of research with adolescents shows steady 
increases in HbA1C levels throughout adolescence, often plateauing at high levels around 
the age of 17 and remaining high through young adulthood (e.g., Clements et al., 2016).  
 During childhood, T1D management tasks are primarily the responsibility of 
caregivers. During adolescence, this responsibility begins to transfer to the youth in 
preparation for adulthood. This transition period can be one of the most difficult times for 
adolescents with T1D (Garvey et al., 2012). Because adolescents are physically able to 
complete adherence tasks, parents may be tempted to quickly hand all responsibility to 
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their children. However, while adolescents may be physically prepared for the increased 
responsibility, they often need help with the decision-making and planning required to 
execute T1D tasks successfully (Herzer & Hood, 2010). This may leave youth feeling 
unsupported and vulnerable, which can result in an avoidance of self-care and follow-up 
care from medical providers. Reduced parental monitoring and poorer communication, 
together with an increase in time spent outside the home (e.g., more extracurricular 
activities and less predictable schedules), are often associated with declines in adherence 
(Amed et al., 2013; Hilliard et al., 2013; Rustad et al., 2013). Conversely, caregivers may 
be hesitant to relinquish control over daily management tasks. This may result in a 
frustrating dynamic in which adolescents wish for autonomy that caregivers are unwilling 
to give. These unpredictable caregiver-adolescent dynamics are often related to poor 
glycemic control (Anderson et al., 2009).  
Of course, it is not the case that adherence and glycemic control decline 
universally across individuals. A multitude of physiological, psychological, and 
contextual factors affect adolescents’ ability to manage the many adherence tasks 
involved in maintaining optimal glycemic control. A longitudinal study of over one 
thousand youth with T1D found that significant deteriorations in glycemic control 
occurred over the first six years after diagnosis for adolescents. Moreover, psychosocial 
burden was a specific contributor to these suboptimal glycemic outcomes (Hood et al., 
2014). The following section will review research examining specific psychosocial 
factors that are associated with adherence and glycemic control in adolescents.  
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Psychosocial Factors Related to Adherence in Adolescents with T1D 
Research has documented that a wide variety of psychosocial factors are related to 
adherence behaviors, and glycemic control by extension, in adolescents with T1D. Some, 
such as negative mood and affect, have been researched for years; others have been 
explored only more recently. Before exploring how psychosocial factors fluctuate on a 
daily basis in this population, it is necessary to thoroughly review the research exploring 
global relationships between these factors and adolescents’ ability to complete 
management tasks and glycemic control. 
Anxiety 
Negative mood and affect have long been established as psychological factors 
with a reliable relationship to both adherence and glycemic control in individuals with 
T1D. Depression and anxiety both stand out as internalizing syndromes that are prevalent 
in this population. An early study of youth with diabetes showed that nearly 50% of 
adolescents were diagnosed with a psychiatric disorder within 10 years of their T1D 
diagnosis, and chief among them was depression (Kovacs et al., 1997). Hood and 
colleagues (2006) found that nearly one in seven youth with T1D report clinically 
significant symptoms of depression, which is nearly double the highest estimates of rates 
in the general adolescent population. Although specific rates vary between studies based 
on methods of measurement, an abundance of research has reported concerning rates of 
internalizing symptoms in adolescents with T1D.  
Anxiety is a leading concern in this population. Silverstein and colleagues (2005) 
reported that over 18% of youth with T1D are diagnosed with an anxiety disorder at some 
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point during their childhood or adolescence, and a more recent study found that a similar 
proportion (21.3%) of their sample screened positive for an anxiety disorder (Bernstein et 
al., 2013). Additionally, relationships between increased anxiety symptoms and poorer 
adherence and glycemic control are well documented (e.g., Herzer & Hood, 2010). A 
recent meta-analysis confirmed that a high proportion (i.e., 32%) of adolescents with 
T1D report symptoms of anxiety, and that these symptoms are associated with poorer 
glycemic control (Buchberger et al., 2016). Trait (i.e., baseline) anxiety has been 
associated with increased fear of hypoglycemia, increased rates of hypoglycemia, 
decreased rates of BG monitoring, and poorer ability to distinguish between physiological 
symptoms of anxiety and hypoglycemia (Rechenberg, Whittemore, & Grey, 2017).  
The directionality of the relationship between anxiety and poor glycemic control 
is unclear. Some work shows that diabetes-related worries negatively impact adherence 
and glycemic control (e.g., Mortensen, 2002; Naar-King et al., 2006). Conversely, 
Gonder-Frederick and colleagues (2006) found that a history of hypoglycemic episodes 
predicts current diabetes-related stress and anxiety, implying that poor glycemic control 
in the past impacts current anxiety about diabetes. Thus, it is not clear whether poor 
glycemic control elicits anxiety or if the opposite is true; the relationship is likely 
bidirectional. Herzer and Hood (2010) examined the prevalence of internalizing 
symptoms in adolescents with type 1 diabetes and associations between anxiety and 
glycemic control in this population. In congruence with prior research, results indicated 
that adolescents experiencing higher levels of both state and trait anxiety and higher 
levels of depression checked their BG less frequently per day and had poorer long-term 
glycemic control. Thus, it is possible that symptoms of anxiety may interfere with 
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adolescents’ ability to complete adherence tasks, negatively impacting glycemic 
outcomes. Conversely, the daily demands and variable outcomes of T1D disease 
management may contribute to increase symptoms of anxiety in these youth. However, 
the specific mechanisms of the relationship between anxiety and glycemic control, and its 
negative impact on the health of these youth, are poorly understood.  
General and Diabetes-Specific Stress 
Stress has also been explored as a factor that plays a role in adolescents’ glycemic 
control. Adolescents in the U.S. report general stress at rates equal to or higher than their 
adult counterparts (American Psychological Association, 2018). Primary stressors in this 
age group include gun violence, the political climate, money, and health-related concerns. 
For adolescents with T1D, the disease diagnosis is a significant additional stressor. 
Helgeson and colleagues (2010) conducted a longitudinal study and found that frequency 
of stressful life events predicted psychological distress, poorer self-care behavior, and 
poorer glycemic control. These associations were stronger among older adolescents (e.g., 
ages 15-17) than younger ones (e.g., ages 11-14).  
Not all stress is created equal, especially for individuals with chronic illnesses. 
The distinction between general stress (GS) and diabetes-specific stress (DSS) is an 
important one when exploring diabetes-related outcomes such as adherence and glycemic 
control. Adolescents and parents report frequent problems related to hyperglycemia or 
hypoglycemia, forgetting to check their BG levels, and leaving supplies at home 
accidentally (Beveridge et al., 2005; Fortenberry et al., 2012). DSS as a construct thus 
focuses on stress related to these diabetes-specific problems. This distinction between GS 
and DSS is an especially important one given past research showing that diabetes-specific 
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stress is uniquely related to poor diabetes outcomes (Farrell et al., 2004). Chao et al. 
(2016) explored general and diabetes-related stressors in adolescents with T1D and found 
that the vast majority of teens reported school as a top stressor, followed by social life, 
and diabetes. Diabetes stressor themes included having diabetes, dealing with emotions 
related to diabetes, and diabetes management.  
Although Chao and colleagues noted that teens perceived GS more frequently 
than DSS, related research has shown that DSS is uniquely related to poor glycemic 
control. Farrell and colleagues (2004) explored both perceived GS and perceived DSS 
and their respective associations with adherence behaviors and glycemic control (i.e., 
HbA1C). Results revealed that greater DSS was directly related to higher HbA1C (i.e., 
poorer glycemic control), while greater GS was only indirectly associated with higher 
HbA1C via poorer adherence behaviors. Conversely, DSS was not related to adherence 
behaviors, which led the authors to conclude that GS may be more disruptive to daily 
routines given that it involves multiple domains of adolescents’ lives. Hagger and 
colleagues (2016) conducted a systematic review of “diabetes distress” in adolescents, 
which they defined as negative emotions that arise from living with T1D. While this 
construct likely includes more than just DSS, researchers found that associations between 
“diabetes distress” and HbA1C were strongest when distress was assessed with the 
Diabetes Stress Questionnaire (Berlin et al., 2012), which specifically measures DSS. 
This finding implies a close relationship between DSS and glycemic control. 
Additional research has underscored the nuances of DSS experienced by this 
population and implications for health-related outcomes. Berlin, Rabideau, and Hains 
(2012) examined patterns of subtypes of perceived DSS among youth with T1D. Three 
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pattern profiles of perceived DSS emerged including low stress, interpersonal/peer stress, 
and family stress. The group of adolescents who reported family stress as primary also 
had significantly higher HbA1C values than adolescents who reported experiencing 
primarily the other two types of DSS. These results are consistent with what is known 
about diabetes-specific family conflict and the potential for turmoil during adolescence as 
responsibility for disease management transitions from caregiver to teen (Williams et al., 
2009). This research highlights the fact that global measures of stress may not sufficiently 
account for associations between perceived stress and glycemic control. Thus, it is 
important to account for adolescents’ perceptions of their diabetes-specific stress and 
appraisal in order to promote optimal disease management. 
Taken together, the results of the studies reviewed here indicate that both anxiety 
and stress have important, established relationships with adherence and glycemic control 
in adolescents with T1D. Although in most cases directionality has yet to be established, 
it is clear that poor psychosocial functioning has negative implications for diabetes 
management in this population. The majority of the studies reviewed thus far have 
utilized one-time recall measurements of all variables. While studies using these 
approaches are crucial to the establishment of global relationships between psychosocial 
factors and diabetes-related outcomes in this population, the following section will 
review studies that employ more nuanced, ambulatory approaches to explore these 
relationships further. 
EMA as a Methodology 
 Behavioral scientists aim to study human behavior, thoughts, and emotions in 
ways that allow them to draw conclusions about participants’ everyday real-world 
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experiences. However, such behaviors, thoughts, and emotions are most often studied in 
the context of a lab, hospital, or other artificial setting that bears many distinctions from 
individuals’ typical lives. Such approaches arose out of a desire to control the experiences 
of participants; however, in doing so, researchers often render findings ungeneralizable to 
other settings. Furthermore, individual experiences are often studied globally via one-
time recall self-reports that ask participants to report on a summarized experience over a 
long period of time (e.g., level of anxiety over the past six months), which introduces the 
potential for recall bias (Shiffman et al., 2008).  Psychological research often asks 
participants to summarize their experiences over a period of time (e.g., “how intense was 
your pain over the past month?”). The longer this period of time, the more participants 
rely on cognitive heuristics to estimate a response (Margetts et al., 2003). In psychology 
especially, it is important to focus on short-term reports in order to understand how 
thoughts, feelings, and behaviors may vary over brief periods of time. Many psychosocial 
factors undergo dynamic changes from day to day or from moment to moment. 
Psychological researchers’ reliance on one-time recall data fails to consider such real-
world, dynamic processes. It is crucial to examine data on a more immediate level in 
order to better understand the mechanisms underlying global patterns that have been 
observed.  
 “Ecological momentary assessment” does not refer to one single method of data 
collection, but rather to a range of assessment methods that are naturalistic, ambulatory, 
and real-time (Heron et al., 2017). These methods include daily diaries (both paper/pencil 
and electronic), experience sampling, and ambulatory monitoring of physiological 
parameters. EMA as a group of methodologies can be especially helpful in answering 
 14 
research questions relating to the impact of environmental or situational factors (e.g., 
comparing adherence behaviors at school and at home); natural day-to-day fluctuations in 
thoughts, feelings, or behaviors; or the impact of internal factors (e.g., relationships 
between daily stress and adherence behaviors). EMA emerged fairly early in the history 
of behavioral research, as many behavioral scientists designed studies asking participants 
to record information about their subjective experiences (e.g., behaviors, thoughts, 
emotions, social interactions) over time (Shiffman et al., 2008). EMA was also used early 
in the field of health psychology as a way of checking the accuracy of health-related self-
report data about illness episodes (Thiele et al., 2002). 
EMA is an increasingly popular method of data collection in the social and health 
sciences, including with child and adolescent populations, and it holds many advantages 
for behavioral researchers. The administration approach allows participants to complete 
surveys and diaries in a naturalistic setting; often participants complete measures on a 
home computer or mobile phone, or they are given paper-pencil measures to fill out over 
the course of a week or month. Researchers using EMA recognize that many behaviors 
and experiences are influenced by the environment, and thus it is imperative to sample 
behaviors and experiences in the context in which they typically occur (Shiffman et al., 
2008). This increases the ecological validity of collected data.  
Unfortunately, all self-reported data is subject to recall biases that threaten their 
validity. Additionally, recall bias is not evenly distributed; rather, it is systematic in 
nature. For instance, individuals are more likely to recall negatively-valenced information 
when they are experiencing negative moods (Hassan, 2005). Furthermore, recall depends 
on memory, which can be notoriously unreliable in many ways. Details of an event may 
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not be noticed and therefore not stored in memory. Additionally, memory distorts recall 
even after relatively short intervals, and repeated retrieval of the same memory may lead 
to further distortions or additional information being stored (Bradburn et al., 1987). By 
asking participants to reflect on the past day (or the past few hours), as opposed to a 
longer period of time, EMA researchers decrease the likelihood of errors in memory. This 
is especially relevant to psychological research, in which researchers often ask 
participants to summarize their experiences over a period of time (e.g., “how intense was 
your pain over the past month?”).  
The intensive nature of EMA data collection also allows for a reduction of the 
recall period, which may increase the validity of participants’ responses. This advantage 
is particularly relevant when conducting research with children and adolescents, who may 
face increased struggles in accurately reporting on behaviors and experiences as 
compared to adults (Heron et al., 2017). Specific to pediatric populations, youth may be 
better able to report on subjective experiences of pain and sensation, treatment adherence, 
sleep, and psychological symptoms across shorter time periods. Lastly, EMA data 
collection yields intensive longitudinal data, or data with repeated measurements over a 
relatively short time period, which allow for the examination of within-subject changes in 
behavior and experience over time and across contexts (Shiffman et al., 2008).  
Disadvantages of EMA approaches are few but not insignificant. EMA 
approaches are inherently time-intensive, as they require the repeated assessment of the 
same subjects. This challenge highlights the appeal of bringing participants to the lab to 
complete various one-time measures and is likely a leading reason of why EMA 
approaches, while more comprehensive, are not a default methodology. Researchers must 
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determine how best to administer such assessments repeatedly to participants in their 
homes. Paper diaries, while simple to create, may nevertheless be problematic when 
participants must report times of day at which they are completing measures. Electronic 
diaries will record times automatically, which is important given that studies have shown 
many individuals are not truthful when reporting times of day (Clifford et al., 2014). 
Electronic diaries, however, are not always financially feasible. Many of the most 
successful EMA studies involved researchers giving participants phones or small tablets 
to use over the course of the EMA period, which may come at a significant economic 
cost. Despite the price, Hufford and Shields (2002) argued for the development and use 
of electronic diaries, citing poor data quality and suboptimal compliance with paper 
diaries.  
EMA and Type 1 Diabetes 
EMA methodologies are particularly relevant to research examining the 
management of life with T1D. In addition to daily variation in psychosocial factors, 
youth with T1D experience moment-to-moment fluctuations in their physiology (e.g., 
blood glucose levels). These fluctuations are likely to be accompanied by physiological 
symptoms that may interact with psychosocial factors over the course of a day. 
Additionally, the gold-standard measure of glycemic control, HbA1C, is an oversimplified 
global measure of a factor that fluctuates daily, even from hour to hour. Using HbA1C, an 
average of three months’ worth of BG values, does not consider daily, weekly, or even 
monthly variation that is crucial to the understanding and improvement of glycemic 
control. Additionally, two individuals may have the same HbA1C value over one three-
month period but wildly different BG values during that same period; this would have 
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important implications for potential diabetes-related physiological complications. 
Unfortunately, HbA1C alone may not be the best predictor of later complications. 
Analysis of data from the Diabetes Control and Complications Trial revealed that blood 
glucose variability adds to the risk of microvascular complications from diabetes, above 
and beyond that predicted by HbA1C value alone (Kilpatrick et al., 2008). Although low 
BG value will bring down one’s average BG level, a low BG value does not counteract 
the damage done by a high BG value (and may in fact lead to its own complications). 
Thus, the importance of examining day-to-day adherence and glycemic control is evident.  
As has been reviewed in previous sections, there exists a wealth of research 
establishing relationships between myriad psychosocial factors and glycemic control in 
adolescents with T1D. However, the literature reviewed thus far has exclusively 
examined relationships between HbA1C and psychosocial variables as measured by one-
time recall assessments. More recently, research has begun to examine how some of these 
psychosocial variables vary on a daily basis and the relationship between those variations 
and individuals’ daily BG values. 
Specifically, 11 studies have been conducted with adolescents with T1D utilizing 
EMA methods. The studies employed a variety of data collection methods (see Table 1). 
Across these studies, those with the highest rates of participant compliance were those 
that utilized once daily online surveys for up to two weeks, provided small incentives for 
each completed diary, and contacted participants nightly with reminders or problem-
solving help. These methods were not only the most successful, but they were the most 
popular among the 11 EMA studies reviewed here. These methods appear feasible and 
successful with children and adolescents as young as 10 years old. It is likely that the 
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flexibility of the once daily online survey leads to such high compliance rates; 
adolescents may have benefitted from being able to complete surveys at home in the 
evening, which also provided parents the opportunity to remind them about participation.  
Two exemplary studies (i.e., Baucom et al., 2015; Lansing et al., 2016) utilizing 
EMA methods to great effect in this population explored relationships between daily 
psychosocial functioning and daily BG levels, in addition to examining the role of 
baseline trait characteristics (i.e., self-control and depression, respectively). Lansing and 
colleagues (2016) explored what individual processes link daily self-regulation with daily 
BG levels and the moderating role of self-control. Participants completed a baseline 
measures of self-control and adherence, followed by 14 consecutive days of daily diary 
measures of negative affect about diabetes and number of diabetes problems experienced. 
During this 14-day period, adolescents monitored their BG levels using meters provided 
by researchers. Adolescents with higher baseline self-control experienced less negative 
affect on days when they had many diabetes problems. Higher baseline self-control was 
also related to lower mean BG values and less BG variability. These results support 
previous findings that self-control facilitates effective affect regulation and enables better 
diabetes care, which emphasizes the role of multiple aspects of self-regulation in optimal 
daily diabetes care. 
Given established findings that depressive symptoms are increased in youth with 
more poorly controlled diabetes, researchers have examined to what extent depressive 
symptoms might account for poor adherence in the short term, with the presumption that 
this may be the mechanism contributing to poor long-term glycemic control. Baucom and 
colleagues (2015) explored relationships between daily stress, depressive symptoms, and 
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daily adherence in adolescents with T1D and the possible moderating role of depressive 
symptoms on the relationship between stress severity and daily adherence. Researchers 
also distinguished between general stress and diabetes-specific stress. Again, participants 
completed baseline measures, followed by a 14-day diary of both GS and DSS severity 
and adherence. Not only did this sample report high levels of depressive symptoms, but 
these depressive symptoms were associated with more severe daily stress, poorer daily 
adherence, and poorer glycemic control. Adolescents reported poorer adherence on days 
with more severe DSS, which emphasizes the unique role of specific stress on 
adolescents’ ability to complete adherence tasks each day. Additionally, adolescents high 
in depressive symptoms and high in DSS showed an association between daily DSS and 
adherence behaviors. Hence, among adolescents with T1D, the combination of more 
severe depressive symptoms and high daily DSS may make it particularly challenging to 
manage one’s diabetes.  
In summary, researchers have utilized EMA methods and the resulting intensive 
longitudinal data to establish relationships between daily psychosocial processes and 
glycemic control in adolescents with T1D. Additionally, researchers in this area have 
emphasized the value of combining moment-to-moment assessment of psychosocial 
variables with data from advancing blood glucose monitoring technology (i.e., 
continuous glucose monitors) in order to examine how within-day fluctuations in 
psychosocial processes relate to BG values at the same times. 
Importantly, no study to date has examined relationships between daily stress, 
anxiety, and glycemic control in adolescents. Aikens and colleagues (1992) explored 
relationships between daily GS and HbA1C in adults with T1D and found that individuals 
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with greater fluctuations in daily GS severity had higher HbA1C levels. It is not currently 
known if adolescents with T1D exhibit similar daily stress and glycemic control patterns 
as adults, whether this pattern is the same for both GS and DSS, or whether anxiety plays 
the same moderating role as does depression in this equation (Baucom et al., 2015). 
Given the many daily stressors (both general and diabetes-specific) in the lives of 
adolescents with T1D, it is crucial to explore the psychological and physiological effects 
of stress on this population and furthermore to determine the characteristics of youth who 
are most susceptible to daily fluctuations in stress. 
Present Study Overview and Hypotheses 
Given the nature of T1D management and the possibility for daily fluctuations in 
emotions, stressors, and diabetes-related outcomes, the current study examined 
relationships among stress and glycemic control on a daily level and the potential 
moderating role of trait-level (i.e., baseline) anxiety. This study measured participants’ 
anxiety at baseline and utilized EMA methods to measure daily fluctuations in general 
and diabetes-specific stress. Additionally, BG data for the same period was collected in 
order to evaluate relationships between the psychosocial factors listed above and 
individuals’ daily glycemic control. Daily BG data were averaged to create a mean blood 
glucose (MBG) value for each day of the EMA period, which was used as a measure of 
daily glycemic control. Aims and hypotheses for the present study included the 
following: 
Aim 1: To explore between- and within-person associations between daily stress (i.e., 






1a. Adolescents will exhibit higher MBG levels on days when DSS fluctuates to a 
greater level than their respective averages.  
1b. Adolescents who report higher mean levels of DSS across days will exhibit 
higher MBG levels across days.  
1c. Adolescents will exhibit higher MBG levels on days when GS fluctuates to a 
greater level than their respective averages.  
1d. Adolescents who report higher mean levels of GS across days will exhibit 
higher MBG levels across days.  
Aim 2: To examine whether between-person differences in baseline anxiety levels 
moderate each of these associations. 
 
Hypotheses: 
2a. Adolescents who report higher levels of baseline anxiety will experience 
larger increases in MBG on days when they report higher DSS than their average 
DSS, as compared to adolescents who report lower levels of baseline anxiety.  
2b. Adolescents who report higher levels of baseline anxiety will display a 
stronger positive association between overall DSS and MBG than adolescents 
who report lower levels of baseline anxiety.  
2c. Adolescents who report higher levels of baseline anxiety will experience 
larger increases in MBG on days when they report higher GS than their average 
GS, as compared to adolescents who report lower levels of baseline anxiety.  
2d. Adolescents who report higher levels of baseline anxiety will display a 
stronger positive association between overall GS and MBG than adolescents who 
report lower levels of baseline anxiety.  
 22 
Research Design and Method 
Participants 
Participants in this study included 44 adolescents aged 13 to 17 years with a 
current diagnosis of type 1 diabetes for more than one year. Potential participants with a 
diagnosis of type 2 diabetes were excluded from the study. Adolescents who participated 
in a pilot version of this study in previous summers were eligible for recruitment. A priori 
power analyses indicated that 42 subjects would be necessary in order to have 80% power 
to detect a medium effect size for all hypothesized direct effects at .05 criterion of 
statistical significance.  
A total of 79 participants from two field sites were recruited for this study and 
completed baseline measures: 52 from the California site and 27 from the Nevada site. 
Participants from each site were compared on demographic variables (e.g., age at testing, 
age at diagnosis, race/ethnicity), pump status, CGM status, and RCMAS-2 score. 
Participants from the California site were older than those from the Nevada site, t(77) = 
3.23, p = .002. No other significant group differences were observed. 
Forty-four of the 79 recruited participants completed some or all of the daily 
surveys. Participants who completed daily surveys were compared to those who did not 
on demographic variables, pump status, CGM status, and RCMAS-2 score. Subjects who 
used a CGM were more likely to complete daily surveys than those who do not use a 
CGM, c2 = 7.289, p = .007. No other significant group differences were observed. There 
were no significant differences in daily survey completion between the two sites, c2 = 
1.06, p = .30. Five participants completed one daily survey, two completed two surveys, 
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one completed three surveys, two completed four surveys, two completed five surveys, 
and 32 completed all seven surveys. 
Of the 44 participants who completed daily surveys, 25 uploaded BG data to 
Tidepool®. Participants who completed uploads were compared to those who did not on 
demographic variables, pump status, CGM status, RCMAS-2 score, and mean GS and 
DSS severity. Girls were significantly more likely than boys to complete an upload, c2 = 
6.68, p = .01. No other significant group differences were observed.  
Procedure 
 Participants were recruited from diabetes camps located in California and Nevada 
in the summer of 2019. Parents of children who were registered for camps hosted by the 
Nevada Diabetes Association and Diabetes Youth Families were emailed information by 
the camp directors about the study and the investigators prior to the start of camp. 
Families interested in participating completed online parent permission forms. In-person 
recruitment also took place immediately before the start of each camp.  
 Adolescents whose parents gave permission for their participation gave written 
assent before proceeding with study procedures. For each stage of data collection they 
completed, participants were entered to win one of three $25 gift cards.  
 Following individual assent, participants completed an initial survey of baseline 
anxiety on an iPad (Stage 1). Following camp, participants were contacted and asked to 
complete seven daily surveys assessing general and diabetes-specific stress (Stage 2). 
This occurred in the fall when participants had returned to school and other typical 
activities in order to increase the ecological validity of the data. Participants were 
intentionally asked to participate after their first week back at school in order to capture a 
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representative school week. Weeks with school holidays (e.g., Labor Day) were also 
avoided when possible. The survey period began on Monday and ended on Sunday. 
Surveys were sent each day via email or text message to either the participant or their 
caregiver, depending on participant preference. Daily reminders were sent to participants 
if they had not completed the survey by an agreed-upon time of day. After this period of 
daily diary completion, participants were asked to upload their BG data (Stage 3), which 
included BG data concurrent with the daily survey period. BG data were uploaded via 
Tidepool®, which is an open-source, FDA-approved website that allows researchers to 
access patient data.  
Measures 
Revised Children’s Manifest Anxiety Scale – Second Edition (RCMAS-2) 
The RCMAS-2 (Reynolds & Richmond, 2008) is a 49-item self-report measure of 
anxious thoughts, feelings, and behaviors (see Appendix A). Questions are presented in a 
simple yes/no format, and adolescents typically spend 10 minutes or less completing the 
measure. Individual item scores are used to calculate a total anxiety score in addition to 
subscales scores of physiological anxiety, worry, and social anxiety. Subscale scores 
were determined by a factor analysis of the full reference sample of 3,086 U.S. children 
and adolescents (Reynolds & Richmond, 2008).  
The RCMAS-2 (and previous versions of the measure) have been used to assess 
anxiety in adolescents with T1D (Helgeson & Novak, 2006; Kamps et al., 2005) and 
adolescents with various chronic illnesses (Houck et al., 2006). A meta-analysis of 
anxiety in children with chronic illnesses found that ratings of anxiety using the RCMAS 
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in this population were similar to those on other well-validated measures (e.g., Behavior 
Assessment System for Children, State-Trait Anxiety Inventory for Children; Pinquart & 
Shen, 2011). In the current sample, internal consistency for the full scale as measured by 
Cronbach’s alpha was good (a = 0.87). In the present study, total anxiety score T-scores 
(mean score of 50, standard deviation of 10) were used for analyses. 
Demographics 
Adolescents were asked to report on date of birth, diabetes diagnostic status, age 
of diagnosis, gender, grade in school, race, ethnicity, and pump/CGM status (see 
Appendix B). Demographic variables were collected to describe the sample and were 
used to assess for potential group differences.  
Daily General Stress (GS) 
Participants completed a checklist of five daily events related to general stress 
(i.e., argument or disagreement with someone, problem with school or schoolwork, 
problem with work or chores, having to deal with other people’s problems, and problem 
related to where they live or things they own; see Appendix C). These items were adapted 
by Baucom and colleagues (2015) from the Daily Inventory of Stressful events (Almeida 
et al., 2002). Participants indicated whether they experienced each stressful event that day 
and how stressful each endorsed event was on a scale of 1 (not stressful at all) to 5 (as 
stressful as it can get). For each event endorsed, adolescents also indicated whether it was 
related to their diabetes. This was rarely the case for these general stress events: argument 
or disagreement with someone (18.8%), problem with school or schoolwork (15.8%), 
problem with work or chores (40.0%), having to deal with other people’s problems 
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(4.3%), problem related to where they live or things they own (40.0%), broadly 
consistent with previous research utilizing this measure (Baucom et al., 2015). Overall, 
18.2% of general stress events were related to diabetes. Daily general stress (GS) severity 
was calculated by taking the sum of the ratings across general stressors endorsed, divided 
by the number of total items (i.e., five). Thus, items that were not experienced were 
accounted for with a rating of zero. No prior reliability information is available for this 
measure. Previous research using this scale has revealed relationships between daily GS 
and depressive symptoms (Baucom et al., 2015).  
Daily Diabetes-Specific Stress (DSS)  
Participants completed a checklist of five daily events related to diabetes-specific 
stress (i.e., problem with high/low blood sugar, forgetting or skipping a BG test, taking 
the wrong amount of insulin, feeling bad because of diabetes, and problem with pump or 
CGM; see Appendix C). These items were developed by Baucom and colleagues (2015) 
from coding of open-ended descriptions of mother- and adolescent-reported diabetes 
events (Beveridge et al., 2005). Participants indicated whether they experienced each 
stressful event that day and how stressful each endorsed event was on a scale of 1 (not 
stressful at all) to 5 (as stressful as it can get; Baucom et al., 2015). Daily diabetes-
specific stress (DSS) was calculated by taking the sum of the ratings across diabetes 
stressors divided by the number of total items (i.e., 5). Thus, items that were not 
experienced were accounted for with a rating of zero. No reliability information is 
available for this measure. Previous research using this scale has revealed relationships 
between daily DSS, glycemic control, and depressive symptoms (Baucom et al., 2015). 
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Daily Glycemic Control  
Participants were asked to report their daily BG values. Previous studies 
comparing self-reported BG values with meter downloads have found no significant 
differences between values (Herzer & Hood, 2010; McGrady et al., 2009), and self-
reported BG values have been solely used in past EMA studies with this population (e.g., 
C. A. Berg et al., 2014). BG data collected varied depending on participants’ technology 
and device usage. Participants who check their BG values with meters were asked to 
report all BG values for the given day, in addition to corresponding time stamps. 
Participants who use a CGM were asked to report their BG levels for the current day at 
the following times: 6:00 am, 9:00 am, 12:00 pm, 3:00 pm, 6:00 pm, and 9:00 pm (if 
applicable). Daily BG values were averaged to generate daily mean blood glucose 
(MBG) values and daily standard deviation of blood glucose values (SDBG). 
Blood Glucose Data Uploads  
Participants were asked to upload blood glucose data (from a meter or a CGM) for 
the seven days for which they completed daily diaries to a secure website using 
Tidepool®. Information about devices used by each participant was gathered at 
recruitment. Private accounts were created for each participant that could only be 
accessed by the research team. Participants were sent instructions specific to their devices 
and were provided with technical support as needed.  
Preliminary Analyses 
Multilevel model analyses, conducted through SPSS v.25.0, were utilized to allow 
for use of intensive longitudinal data and simultaneous consideration of between- and 
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within-subjects effects. Missing data were accounted for using full information maximum 
likelihood. Therefore, all data points (i.e., individual daily surveys) were included in the 
dataset regardless of how many of the seven daily surveys each participant had 
completed. Separate variables were calculated to quantify between- and within-subjects 
variance of daily diary predictor variables. Specifically, mean GS and DSS severity were 
calculated as each participant’s average score on each respective scale across all seven 
diary days. These values were also grand mean centered. Within-subjects variance in GS 
and DSS severity (i.e., daily fluctuations in GS and DSS severity) were calculated by 
subtracting each participants’ mean score on that scale from their score for each diary day 
(i.e., person centering). For any analysis that included GS or DSS severity, both mean 
severity and daily fluctuations in severity were entered simultaneously in order to account 
for both types of variance separately. In all models, time (i.e., day 1, day 2, day 3, etc.) 
was accounted for but was not a significant predictor. 
BG data were used to create two BG-related outcome variables: mean BG values 
(MBG) were calculated by averaging participants’ BG levels each day; standard 
deviation of BG (SDBG) was calculated as the standard deviation of participants’ BG 
levels each day. These daily outcome variables were entered into models as single, non-
transformed variables that contain both between- and within-subjects variance. Gender, 
age at diagnosis, and pump status were considered as covariates given that these variables 
have known associations with glycemic control (Palmer et al., 2004). There was minimal 
variability in the pump status variable (i.e., 93% of the sample reported using a pump) 
and thus the decision was made to exclude it from further analyses. Gender and age at 
diagnosis were entered into all models as covariates. 
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To examine between- versus within-subjects variance in daily diary measures, 
intraclass correlation coefficients (ICCs) were calculated for DSS and GS severity, MBG 
values, and SDBG values across the measurement period. ICCs indicated that 44% of the 
variation in DSS severity, 33% of the variation in GS severity, 56% of the variation in 
MBG, and 42% of variation in SDBG was between-subjects.   
Blood Glucose Values 
In the final sample of 44 participants, 25 (56.8%) completed BG data uploads via 
Tidepool®. All participants provided self-report BG values. In order to explore the 
accuracy of self-reported BG values, these values were compared to Tidepool® BG 
values for participants who provided BG data uploads (n = 25). Self-reported BG values 
were separated into between- and within-subjects variance and regressed onto Tidepool 
BG values (both MBG and SDBG, respectively). Results indicated that, for MBG, the 
model was significant, F(2, 157) = 113.63, p < .001, and both average self-reported MBG 
across the week, B = 0.91, SE = .07, p < .001, and fluctuations in self-reported MBG, B = 
0.59, SE = .07, p < .001, were associated with Tidepool® MBG. Similarly, for SDBG, the 
model was significant, F(2, 156) = 37.97, p < .001, and both average self-reported SDBG 
across the week, B = 0.85, SE = .13, p < .001, and fluctuations in self-reported SDBG, B 
= 0.38, SE = .06, p < .001, were associated with Tidepool® SDBG. Thus, it was 
concluded that self-reported BG data in this sample were reasonably accurate. For all 
main analyses reported here, Tidepool® BG data were used when available (n = 25) due 
to their objectivity and increased accuracy, and self-reported BG data were used for all 
other participants (n = 19). Notably, all models presented in the Results section were also 
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run using a) only Tidepool® data for those who had it, and b) only self-report data for all 
participants, and the same pattern of results was found in all cases. 
Pilot Testing 
 Pilot testing for the present study was conducted in order to assess feasibility of 
the current data collection method. Fifty participants between the ages of 11 and 17 were 
recruited from Nevada camps. All participants completed baseline measures at camp. 
Two months later, all 50 participants were contacted for follow-up. Twenty-nine (58%) 
responded and agreed to complete five days of EMA measures. Daily reminders were 
sent as described in the procedure section above. Over the five-day period, 28 
participants completed at least one daily diary. Following the EMA period, those 28 
participants were asked to upload BG data. Six participants completed the upload. No 
incentives were offered for any stage of data collection.  
 Results of pilot testing suggest that adolescents and their parents are generally 
willing to enroll in studies with no offer of incentives and complete baseline measures at 
the time of recruitment. However, motivation to complete later stages of data collection 
may have decreased as time passed from recruitment. Thus, in the present study, 
incentives were offered after each stage in order to increase the likelihood that 
participants will complete all stages of data collection. The EMA period was lengthened 




Tables 3 and 4 present descriptive statistics for key study variables and 
correlations among these variables. Bivariate correlations were conducted between mean 
levels of DSS severity, GS severity, MBG, and SDBG values (i.e., averaged across the 
seven-day measurement period) and RCMAS scores. Adolescents with higher mean DSS 
severity were also more likely to report higher mean GS severity. Mean MBG and mean 
SDBG were positively correlated.  
Average anxiety symptom scores in the present study were below the suggested 
clinical cutoff (i.e., T-score of 60), but 25% of the present sample (n = 11) scored in the 
subclinical or clinically significant range. This finding is broadly consistent with prior 
research indicating relatively high levels of trait anxiety in adolescents with T1D as 
compared to their health peers (Buchberger et al., 2016).  Adolescents who reported 
higher anxiety at baseline also experienced higher average levels of DSS severity across 
the measurement period.  




 Multilevel models were conducted to test the first hypotheses that higher levels of 
DSS and GS severity would be related to higher MBG values. Results of all models can 
be found in Table 5. Increased within-subjects fluctuations in daily DSS severity were 
associated with higher daily MBG values. Results indicated that for every 1-point 
increase in diabetes-specific stress severity, MBG was higher by 9.44 mg/dl. Conversely, 
between-subjects differences in average DSS levels across the measurement period were 
not associated with daily MBG values. Similarly, neither within-subjects fluctuations in 
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daily GS severity nor between-subjects differences in average GS levels were associated 
with daily MBG values. Thus, Hypothesis 1a was supported, but Hypotheses 1b, 1c, and 
1d were not. 
Anxiety as a Moderator of the Relationship Between Fluctuations in Daily Diabetes-
Specific Stress Severity and Mean Blood Glucose 
 
 
 Given the null results of Hypotheses 1b, 1c, and 1d, only hypothesis 2a was 
tested. To test the hypothesis that trait anxiety would moderate the association of 
fluctuations in DSS severity with MBG, a moderation model was conducted predicting 
MBG. Inconsistent with the hypothesis, trait anxiety did not moderate the relation of 
within-subjects fluctuations in daily DSS severity with daily MBG. Individuals’ levels of 
trait anxiety did not affect the slope of the relationship between fluctuations in daily DSS 
severity and daily MBG levels. 
Exploratory Analyses 
 Although hypotheses focused on the ability of psychosocial variables to predict 
daily mean blood glucose values (MBG), exploratory analyses were conducted to 
examine relationships between key study variables and standard deviations of daily blood 
glucose values (SDBG) given existing research demonstrating that BG variability is a 
clinically significant health outcome (Hoffman et al., 2016). Multilevel models were 
conducted to test the associations between DSS and GS severity and SDBG. No 
significant associations were found between daily SDBG values and within-subjects 
fluctuations in daily DSS severity, between-subjects differences in average DSS levels, 
within-subjects fluctuations in daily GS severity, or between-subjects differences in 
average GS levels. As with MBG, moderation models were run to test the potential 
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moderating role of trait anxiety on relationships between stress and SDBG, and none 
were found to be significant. 
 Additionally, multilevel models were conducted to explore the potential additive 
effects of fluctuations in both DSS and GS severity on blood glucose levels.  There is 
some research to suggest that the combination of increases in DSS and GS together might 
impact BG outcomes more than either independently (Rechenberg, Whittemore, Holland, 
et al., 2017). However, the interaction between fluctuations in DSS and GS severity did 
not have a significant impact on daily MBG levels or on daily SDBG levels. 
Discussion 
The present study explored relationships between daily stress (both general and 
diabetes-specific), daily blood glucose levels, and trait anxiety in adolescents with T1D. 
Ecological momentary assessment, a relatively new approach to research with 
adolescents, was utilized to gather data that allowed for the examination of both between- 
and within-subjects processes. This study was also innovative in its use of objective 
measures of daily glycemic control (i.e., data uploaded from glucometers or continuous 
glucose monitors), and it was the first to explore the potential moderating role of anxiety 
symptoms on the relationship between stress severity and daily glycemic control.  
Results indicated that within-subjects fluctuations in daily diabetes-specific stress 
(DSS) were predictive of daily glycemic control (i.e., mean daily blood glucose levels). 
By contrast, between-subjects differences in average levels of DSS across the 
measurement period did not play a significant role in predicting mean daily blood 
glucose. This suggests that on days when DSS levels are higher than an individual’s own 
typical level, glycemic control suffers as a result. However, individuals’ respective 
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average levels of DSS do not differentiate their glycemic control. This result highlights 
the importance of individual stress management by demonstrating that intraindividual 
variability in stress is associated with poorer glycemic control. These findings also 
underscore the subjectivity of perceived stress and the extent to which stress is the result 
of one’s personal interpretation of a situation and subjective psychosocial conditions 
(Lindfors et al., 2017; Schraml et al., 2011). This subjectivity may further explain why 
between-subjects differences in average levels of both diabetes-specific and general stress 
did not differentiate glycemic control in this sample. However, DSS is distinguished from 
GS in predicting glycemic control because at the individual level, atypically high DSS 
severity on a given day predisposes adolescents to higher BG levels. Notably, the 
directionality of this relationship is unclear. It is possible that high levels of DSS impede 
good diabetes management by decreasing adolescents’ ability to complete daily 
adherence tasks and thereby worsen glycemic control. It may also be that high blood 
glucose levels on a particular day trigger an increase in DSS severity, especially for those 
adolescents who are attentive to their BG levels and attempt to maintain good glycemic 
control. 
Contrary to hypotheses, GS severity was not predictive of daily MBG at either 
level of variance. Neither average levels of GS across the measurement period nor daily 
fluctuations in GS were related to glycemic control. Existing research on the distinction 
between GS and DSS is mixed, and the role of each in predicting diabetes outcomes is 
unclear. In accordance with the present findings, Baucom and colleagues (2015) found 
that GS severity was not related to daily adherence behaviors or glycemic control (as 
quantified by HbA1C), while DSS severity was. Rechenberg and colleagues (2017) also 
 35 
examined both types of stress and found that while GS and DSS were each independently 
related to diabetes outcomes, when both types of stress were entered into the same model, 
GS no longer contributed significantly to glycemic control. However, GS did maintain its 
contribution to adherence behaviors. Similarly, Farrell and colleagues (2004) found that 
daily GS severity was only associated with glycemic control via adherence behaviors. 
Importantly, the present study examined only glycemic control as an objective outcome 
and not adherence behaviors. Thus, based on these and prior findings, it may be that GS 
plays a role in management behaviors but does not directly impact glycemic control. For 
example, experiencing high levels of GS severity may direct adolescents’ attention away 
from completing adherence tasks throughout the day, while resulting glycemic control 
(i.e., BG levels) is more likely to directly impact (or be impacted by) DSS severity. 
Notably, in the present study, average DSS levels across the sample were higher than 
those of GS, which is in contrast to some other studies that have found GS more 
prevalent in adolescents (Chao et al., 2016). This may be related to the timing of our 
study; most of the daily diary data were collected early in the fall, when participants may 
have been experiencing relatively low levels of school- and peer-related stress. By 
contrast, diabetes-specific stressors (e.g., taking the wrong amount of insulin, forgetting 
to check BG levels) are constantly present for these adolescents. 
Interestingly, no significant relationships were found between DSS or GS severity 
and SDBG. While it is known that glycemic variability (such as SDBG) is related to 
significant health outcomes for individuals with T1D (e.g., inflammation and 
microvascular complications; Gorst et al., 2015; Hoffman et al., 2016), fewer studies 
have examined relationships between SDBG and psychosocial outcomes. Notably, SDBG 
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may be a better indicator of individuals’ daily experiences of hyper- and hypoglycemia 
than of overall glycemic control and, by extension, chronic diabetes complications. 
However, long-term glycemic variability is known as a potential barrier to achieving 
optimal glycemic control (McCall & Kovatchev, 2009). It is also important to consider 
the fact that participants in this study reported very high rates of diabetes technology use 
compared to the general pediatric diabetes population (Miller et al., 2015). This may have 
resulted in relatively low levels of glycemic variability over the measurement period, 
which could explain the lack of findings regarding SDBG. It is possible that in a sample 
with increased glycemic variability, relationships between DSS and SDBG would 
emerge. Although the present findings do not provide evidence that daily SDBG is 
associated with daily stress in this population, it is important to continue studying 
glycemic variability in order to gain a full picture of diabetes control and risks in patient 
populations.  
Anxiety was not found to play a significant role in the relationship between daily 
stress severity and glycemic control. At the correlational level, RCMAS-2 total scores 
were related only to average DSS severity. There are several potential explanations for 
this. First, it is possible that different subtypes of anxiety would play a more meaningful 
role in these relationships. For example, relationships between fear of hypoglycemia 
(FOH) and glycemic control are mixed, but FOH is related to poorer quality of life in 
both children and their parents (Driscoll et al., 2016). FOH may therefore impact 
adolescents’ approach to dealing with daily stressors and subsequent daily BG levels. 
Second, it is important to highlight the distinction between trait and state anxiety. Trait 
anxiety refers to an individual’s general level of anxiety (which was measured in this 
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study), while state anxiety refers to in-the-moment anxiety levels. Specifically, the 
RCMAS-2 asks respondents to report on whether items are “true of you,” as opposed to 
asking about their current state or their feelings in a given situation (Reynolds & 
Richmond, 2008). Previous studies examining anxiety in adolescents with T1D have 
found that while trait anxiety is related to BGM frequency, state anxiety is related to both 
BGM frequency and glycemic control (i.e., HbA1c; Herzer & Hood, 2010). Hilliard and 
colleagues (2011) also found that state anxiety levels were significantly related to HbA1C; 
trait anxiety levels were not measured in this study. Thus, it is possible that trait anxiety 
affects daily adherence tasks but is not significantly related to objective outcomes such as 
BG levels or HbA1C. In a recent review of anxiety in youth with T1D, Rechenberg and 
colleagues (2017) proposed that trait anxiety is related to FOH and hypervigilance of 
physiological symptoms, while state anxiety is more closely related to outcomes 
including HbA1C and BGM frequency. Future research incorporating state anxiety into 
daily diary surveys, instead of assessing trait anxiety at baseline, may illuminate this 
relationship further. 
It is also important to consider ways in which the timing of measure 
administration may have impacted participants’ scores. Although RCMAS-2 scores 
should yield generic levels of trait anxiety, it is possible that anxiety symptoms were 
underreported given that participants were in a relatively low-stress camp environment 
when they completed the measure. As noted above, RCMAS-2 instructions do not 
indicate a specific reporting period, but instead the instructions ask participants whether 
or not each item is true of them. Adolescents have particular difficulty accurately 
reporting symptoms when compared to adults, especially when they are asked to estimate 
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their experiences over an extended or unspecified period (Kamphaus & Frick, 2005). 
Participants may have had difficulty estimating their anxiety symptoms while in a 
pleasant and stress-free environment, making them more likely to rely on cognitive 
heuristics to respond to items (Margetts et al., 2003). RCMAS-2 total T-scores in the 
present study were broadly unremarkable or subclinical in nature. Data on rates of 
clinical anxiety in this population are mixed; it is widely accepted that youth with T1D 
demonstrate higher rates of anxiety symptoms than their health peers, but regarding 
“clinically significant” scores, threshold cutoffs are inconsistent across studies 
(Buchberger et al., 2016). Thus, it is difficult to say how this sample compares to others 
regarding anxiety symptoms endorsed, but it is feasible that completing the measure 
while at camp depressed scores somewhat.  
Lastly, it is worth noting that moderation analyses involving anxiety scores were 
likely underpowered to detect significance, given that a priori power analyses were 
conducted for the analyses proposed in Hypothesis 1. Therefore, it may be the case that a 
larger sample size would yield significant relationships between anxiety and other key 
study variables. 
Taken together, the present findings indicate that while fluctuations in daily DSS 
severity account for some variability in daily MBG levels, there is more to the equation 
than was accounted for in this study. An important factor to consider, and one that was 
not measured here, is the role of individual coping styles in response to stressors. Existing 
research on coping styles in adolescents with T1D has revealed differences in diabetes 
outcomes based on individual coping styles. Broadly, avoidant (or emotion-focused) 
coping are related to poorer glycemic control as compared to approach (or problem-
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focused) coping (Delamater et al., 1987; Graue et al., 2004). Jaser and White (2011) 
described three distinct coping strategies: primary control engagement (including 
problem-solving and emotional expression), secondary control engagement (including 
acceptance or cognitive restructuring), and disengagement (including withdrawal or 
denial). Primary control coping strategies were associated with the highest quality of life 
and best glycemic control. Importantly, secondary control coping was also associated 
with better glycemic control (as compared to disengagement), suggesting that secondary 
control may still be helpful for adolescents given that there are some aspects of diabetes 
that cannot be handled with problem-solving. In these cases, acceptance or cognitive 
restructuring appears to be adaptive. Disengagement was consistently associated with 
poor glycemic control.  
Coping styles may thus be an important intermediate factor in the relationship 
between diabetes-specific stress and glycemic control and may explain why in our study, 
stress severity alone did not account for variations in daily BG levels. One study found 
that adolescents who perceive more diabetes-related distress also utilize avoidant coping 
styles, which results in poorer self-management and subsequently poorer HbA1C 
(Iturralde et al., 2017). Maladaptive coping strategies, and particularly passive coping, 
have also been linked to low levels of resilience in this population (Yi-Frazier et al., 
2015). This suggests that proactive problem-solving is the optimal approach when 
individuals encounter diabetes-related stressors. Additionally, low-income and minority 
racial/ethnic status have been linked to avoidant coping strategies in this population, 
suggesting that chronic stress experienced by these individuals may interfere with their 
ability to take a problem-focused approach to diabetes management (Jaser et al., 2012). 
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Thus, the relationship between diabetes-specific stress, coping strategies, and glycemic 
control of adolescents with T1D is an important area for future study. 
Notably, age at diagnosis was a significant predictor of BG levels (both MBG and 
SDBG) in all the models reported in this paper. Younger age at diagnosis was 
consistently associated with higher MBG and SDBG (i.e., poorer glycemic control). This 
finding comports with existing research demonstrating poorer diabetes management and 
self-care behaviors in adolescents with longer T1D diagnosis duration as compared to 
adolescents diagnosed more recently (Austin et al., 2011; Chao et al., 2014). The present 
results underscore the importance of considering duration of diagnosis when estimating 
trajectories of glycemic control across adolescence.  
The present findings must be interpreted in the context of the study’s limitations. 
First, we did not obtain HbA1C values for participants, given that we will not have access 
to their medical records. Research with individuals with T1D often includes HbA1C 
values as measures of long-term glycemic control. We are therefore unable to draw 
conclusions about how these daily psychosocial processes and BG measures relate to 
glycemic control over a longer period of time. In future studies, it would be valuable to 
measure both daily BG levels using CGMs or glucometers and HbA1C levels 
corresponding to the measurement period. This would allow researchers to explore how 
these daily processes contribute to long-term glycemic control in this population. 
Additionally, as mentioned previously, the size of the present sample was likely 
not large enough to detect meaningful relationships in our moderation analyses. In order 
to be confident about the findings of these analyses, a larger sample size is warranted. It 
is also possible that significant relationships in this study would be furthered strengthened 
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by an increase in number of participants. Relatedly, a larger sample size may yield a 
more diverse participant population, which could shed light on the differential 
experiences of distinct racial or ethnic groups. Existing research has shown that not all 
youth with T1D experience stress in the same way. For example, Hispanic/Latinx 
emerging adults show a stronger association between DSS and poor glycemic control 
than do their non-Hispanic white counterparts, and Hispanic/Latinx individuals show 
greater impact of general stress on glycemic control (Butler et al., 2017). A sample with 
more racial/ethnic diversity, or one targeting minority populations, would illuminate 
potential disparities in daily disease processes between groups. That said, the 
racial/ethnic breakdown of the current sample is largely reflective of the demographic 
characteristics of youth with T1D in the U.S. (Miller et al., 2015). 
Relatedly, it is important to consider the characteristics of the camp-attending 
population from which we recruited our sample. As discussed previously, this sample 
reported high rates of technology usage (e.g., 93% of participants reported using CGMs). 
Given the known diabetes-related benefits of CGM use for those with T1D (i.e., 
improved glycemic control; DeSalvo et al., 2018), it is likely that the present sample had 
lower MBG and SDBG than the average adolescent with T1D. There is also evidence that 
adolescents who attend diabetes camps are more involved in their diabetes care, and have 
more involved families, than the average adolescent with T1D (Chae et al., 2014). This 
may have impacted analyses by limiting the variability of BG outcome variables, and also 
limits the generalizability of the present results. Thus, it would be valuable to replicate 
the present study with a sample that is more representative of the general population of 
adolescents with T1D or a higher risk sample (e.g., adolescents with chronically high 
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HbA1C levels or those with low rates of technology use) to determine whether similar or 
different associations between diabetes-specific stress and glycemic control are present.   
Finally, as with many studies using data of this nature, we are unable to draw 
conclusions of causality between daily diabetes-specific stress and glycemic control. This 
is due both to the fact that this study was not experimental in nature and to the fact that 
we could not establish temporal precedence of stress versus BG values. It is possible that 
on a given day, higher BG levels triggered diabetes-specific stress in participants; equally 
plausible, however, is the possibility that diabetes-specific stressors impacted 
participants’ management of their BG and resulted in higher MBG values. Future 
research on daily disease management processes might include multiple daily 
measurement points, which could yield data that exhibit the unfolding of a temporal 
process. The constant and intensive nature of diabetes management calls for a close 
examination of causal processes between psychosocial and disease processes. 
Implications 
Despite its limitations, the present study offers a meaningful contribution to the 
literature on daily processes of adolescents’ management of T1D. The association 
between fluctuations in daily diabetes-specific stress and same-day glycemic control 
highlights the need for clinicians to focus on bolstering adolescents’ adaptive responses 
to daily disease-related stressors. Healthcare providers may incorporate interventions 
targeting coping and stress management that are feasible for adolescents to use daily. 
There have been some explorations of interventions to target DSS in individuals with 
T1D. DSS levels improved following multisystemic therapy (MST) with adolescents with 
chronically poorly controlled T1D (Ellis et al., 2005), although it is important to note that 
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MST is a relatively intensive and costly intervention and therefore not feasible for many 
T1D patients to engage in. Ellis and colleagues (2018) have recently conducted an initial 
exploration of mindfulness-based stress reduction aimed at improving DSS in emerging 
adults, although results were preliminary, and additional research is warranted.  
Researchers in this area have suggested lower cost strategies to help adolescents 
manage DSS, including resilience-building interventions, given that resilience is 
associated with lower levels of diabetes distress and improved quality of life in 
adolescents with T1D (Yi-Frazier et al., 2015). Maladaptive coping styles are likely a 
meaningful point of clinical intervention, given existing research demonstrating links 
between stress, coping, and glycemic control in adolescents with T1D (Iturralde et al., 
2017; Jaser & White, 2011). Adolescents who use approach coping skills are more likely 
to continue to engage in diabetes management behaviors in the face of stressors. 
Teaching adolescents to use proactive problem-solving approaches when they encounter 
diabetes-specific stressors may bolster their ability to handle such stressors and improve 
their ability to maintain good glycemic control despite stressors. Brief stress management 
interventions (e.g., diaphragmatic breathing, mindfulness, and relaxation) may be 
especially relevant to these adolescents, as these are strategies that can easily be 
incorporated into their daily lives. Additionally, it is important to consider adolescents’ 
life experiences when targeting optimal diabetes management. Low-income and minority 
youth may require additional support with managing diabetes stress, especially depending 
on how they cope with poverty and discrimination (Jaser et al., 2012). Culturally relevant 
interventions are also warranted to bolster coping in an effective manner that 
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encompasses holistic considerations of the individual and their environment (Yang et al., 
2019).  
Relatedly, findings of the current study highlight the importance of distinguishing 
between perceived GS versus DSS when planning interventions for individual 
adolescents. High levels of GS may call for generic stress management skills for school- 
and peer-related stress while promoting good diabetes management in a busy schedule. 
Adolescents with higher levels of DSS may benefit instead from interventions targeting 
thoughts and behaviors regarding diabetes management tasks. For example, it may be 
valuable to discuss strategies for checking BG levels and dosing appropriately for food in 
social situations where youth may feel embarrassed.  
Lastly, the use of EMA methodology in this study to collect intensive longitudinal 
data provides further support that such methods are feasible for use with adolescents and 
can provide meaningful results. Compared to our pilot testing, approximately the same 
percentage of participants agreed to complete daily diaries following camp, and a much 
larger percentage of those participants completed BG uploads to Tidepool®. This 
increase may have been due to the introduction of incentives, and it is possible that 
additional incentives would boost participant engagement even further. Researchers 
should continue to develop and utilize EMA designs to further advance the literature on 
psychosocial correlates of disease outcomes in youth with chronic illnesses. 
Conclusions 
The present study utilized innovative methods to collect intensive longitudinal 
data, which allowed for the examination of both between- and within-subjects variance in 
daily stressors. Notably, results revealed distinctions in the predictive roles of average 
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DSS severity versus daily fluctuations in DSS severity. These findings highlight the 
importance of examining both between- and within-person psychosocial processes in 
individuals with T1D in order to fully understand the mechanisms underlying disease 
management. These data allow us to clarify which daily dynamics and which trait-level 
differences play meaningful roles in daily health behaviors and outcomes. The current 
findings provide further evidence, in accordance with prior studies (e.g., Berg et al., 
2017; Lansing et al., 2016), that intra- and interindividual processes are often distinct and 
differentially associated with medical outcomes for youth with T1D. Additionally, 
objective BG data were collected to quantify glycemic control, while other studies of this 
nature have relied on self-report data. Our results demonstrating the link between 
fluctuations in daily DSS severity with concurrent MBG levels provide additional support 
for the need to identify adolescents’ diabetes-related stressors and implement 
interventions aimed at daily stress management. By focusing on both intra- and 
interindividual processes in this population, the present study enhances our understanding 
of adolescents’ daily psychosocial functioning and how it relates to a consequential 
diabetes outcome, daily blood glucose levels. Continued development and improvement 
of brief, feasible interventions to help adolescents maintain optimal glycemic control 
despite inevitable stressors will enable individuals with T1D to thrive.   
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efficacy, daily affect 
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Hema et al. 
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Daily stressors and 
coping strategies 
Paper/pencil Once daily, 
up to 21 
days 
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Phone calls Twice daily, 
10 days 
12 to 17 
years 
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Variable M SD Range n % 
Gender      
Female    30 68.2 
Male    14 31.8 
Age at testing (years) 15.35 1.05 13.39 – 17.64   
Race (select all that apply)      
American Indian/Alaska 
Native 
   0 0 
Asian    5 9.8 
Black/African American    2 3.9 
Hispanic or Latina/o    7 13.7 
Middle Eastern    1 2.0 
Native Hawaiian or Other 
Pacific Islander 
   1 2.0 
White or European 
American 
   35 68.6 
Other    4 7.8 
Age at diagnosis (years) 7.69 3.36 1.50 – 13.50   
Uses a pump    41 93.2 





Descriptive Statistics of Key Study Variables  
 
Variable M SD Range 
Mean blood glucose 179.63 51.08 74.67 – 364.83 
Standard deviation of blood glucose 62.20 26.51 16.40 – 189.13 
General stress severity 0.54 0.69 0.0 – 3.6 
Diabetes-specific stress severity 0.86 1.17 0.0 – 4.6 
Revised Childhood Manifest Anxiety Scale 
     Total T-score 




Bivariate Correlations Between Aggregated Key Study Variables 
 
Variable 1 2 3 4 
1. General stress severity --    
2. Diabetes-specific stress severity .68* --   
3. Mean daily BG (MBG) .24 .25 --  
4. Standard deviation of daily BG (SDBG) .19 .29 .73* -- 
5. Revised Childhood Manifest Anxiety 
Scale, Total T-scores 
.23 .44* .13 .14 
 






Multilevel Models Predicting Mean Daily Blood Glucose Levels 
 
Variable B SE t 95% CI 
Daily Diabetes-Specific Stress (DSS) Predicting MBG 
Intercept 243.12 16.92 14.37*** 206.58 – 279.66 
Intraindividual (Level 1) 
Day 0.68 1.44 0.47 -2.18 – 3.53 
Fluctuations in Daily DSS 9.44 4.50 2.10* 0.0 – 18.89 
Interindividual (Level 2) 
Gender -20.32 13.52 -1.50 -50.35 – 9.71 
Age at diagnosis -6.40 1.78 -3.59** -10.40 – -2.40 
Mean DSS 12.79 10.07 1.27 -8.85 – 34.43 
Daily General Stress (GS) Predicting MBG 
Intercept 234.86 15.70 14.96*** 203.10 – 266.63 
Intraindividual (Level 1) 
Day 0.52 1.30 0.40 -2.15 – 3.20 
Fluctuations in Daily GS 5.54 5.86 0.95 -7.26 – 18.35 
Interindividual (Level 2) 
Gender -14.34 12.07 -1.24 -39.34 – 9.46 
Age at diagnosis -5.78 1.59 -3.64** -9.01 – -2.55 
Mean GS 18.76 11.06 1.70 -3.56 – 41.07 
Daily DSS and Anxiety Predicting MBG 
Intercept 207.51 54.89 3.78** 95.89 – 319.14 
Intraindividual (Level 1) 
Day 0.98 1.89 0.52 -2.72 – 4.68 
Fluctuations in Daily DSS 70.87 34.16 2.08 -4.88 – 146.62 
Fluctuations in Daily 
DSS*Anxiety 
-1.08 0.60 -1.79 -2.43 – 0.27 
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Interindividual (Level 2) 
Gender -18.97 15.21 -1.25 -50.05 – 12.11 
Age at diagnosis -6.93 1.91 -3.63** -10.85 – -3.01 
Mean DSS 9.09 11.15 0.82 -13.60 – 31.77 
Anxiety 0.69 0.98 0.71 -1.30 – 2.69 
Daily GS and Anxiety Predicting MBG 
Intercept 207.39 43.20 4.80*** 120.11 – 294.68 
Intraindividual (Level 1) 
Day 0.47 1.27 0.37 -2.16 – 3.09 
Fluctuations in Daily GS -49.43 37.42 -1.32 -130.54 – 31.68 
Fluctuations in Daily 
GS*Anxiety 
0.97 0.65 1.49 -0.47 – 2.41 
Interindividual (Level 2) 
Gender -18.12 12.73 -1.42 -43.78 – 7.54 
Age at diagnosis -5.33 1.54 -3.45** -8.45 – -2.21 
Mean GS 19.72 10.69 1.84 -1.80 – 41.24 
Anxiety 0.48 0.77 0.63 -1.07 – 2.04 
 





Fluctuations in Diabetes-Specific Stress Predict Daily MBG, While Mean Diabetes-
Specific Stress Does Not 
 
Note. Covariates included in these models are discussed in the text and presented in Table 
5; they are not included here to reduce complexity in the figures.  













Revised Children’s Manifest Anxiety Scale – Second Edition 
Directions: The sentences on the page tell how some people think and feel about 
themselves. Read each sentence carefully, and then circle the Letter that shows your 
answer. Select Yes if you think the sentence is true about you. Select No if you think it is 
not true about you. Give an answer for every sentence, even if it is hard to choose one 
that fits you. There are no right or wrong answers. Only you can tell us how you think 
and feel about yourself. Remember, after you read each sentence; ask yourself “Is this 
true about me?” If it is, select Yes. If it is not, select No.  
 
1. I have trouble making up my mind. YES NO 
2. I get nervous when things do not go the right way for me. YES NO 
3. Others seem to do things easier than I can. YES NO 
4. I like everyone I know. YES NO 
5. Often I have trouble getting my breath. YES NO 
6. I worry a lot of the time. YES NO 
7. I feel bad if people laugh at me. YES NO 
8. I am afraid of a lot of things. YES NO 
9. I am always kind. YES NO 
10. I get mad easily. YES NO 
11. I worry what my parents will say to me. YES NO 
12. I feel that others do not like the way I do things. YES NO 
13. I am afraid to give a talk to my class. YES NO 
14. I always have good manners. YES NO 
15. It is hard for me to get to sleep at night. YES NO 
16. I worry about what other people think of me. YES NO 
17. I feel alone even when there are people with me. YES NO 
18. I get teased at school. YES NO 
19. I am always good. YES NO 
20. Often I feel sick in my stomach. YES NO 
21. My feelings get hurt easily. YES NO 
22. My hands feel sweaty. YES NO 
23. I worry about making mistakes in front of people. YES NO 
24. I am always nice to everyone. YES NO 
25. I am tired a lot. YES NO 
26. I worry about what is going to happen. YES NO 
27. Other people are happier than I am. YES NO 
28. I am afraid to speak up in a group. YES NO 
29. I tell the truth every single time. YES NO 
30. I have bad dreams. YES NO 
31. I feel someone will tell me I do things the wrong way. YES NO 
32. I get angry sometimes. YES NO 
33. I worried about being called on in class. YES NO 
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34. I wake up scared sometimes. YES NO 
35. I worry when I go to bed at night. YES NO 
36. It is hard for me to keep my mind on my schoolwork. YES NO 
37. I sometimes say things I should not say. YES NO 
38. I fear other kids will laugh at me in class. YES NO 
39. I worry about someone beating me up. YES NO 
40. I wiggle in my seat a lot. YES NO 
41. I am nervous. YES NO 
42. A lot of people are against me. YES NO 
43. I have told a lie. YES NO 
44. I often worry about something bad happening to me. YES NO 
45. I fear other people will laugh at me. YES NO 
46. I have too many headaches. YES NO 
47. I worry that others do not like me. YES NO 
48. I get nervous around people. YES NO 





1. What is your date of birth? __________  
2. Do you have type 1 diabetes?  Yes   No 
3. How old were you when you were diagnosed with type 1 diabetes? __________ 
a. Do you know the date of your diagnosis?___________________ 
4. What is your gender? _______________ 
5. What grade will you be in this fall?     
6. What is your race/ethnicity? (Select one or more responses) 
£ American Indian/Alaska Native 
£ Asian 
£ Black or African American 
£ Hispanic or Latina/o 
£ Middle Eastern 
£ Native Hawaiian or Other Pacific Islander 
£ White or European American 
£ Other 
7. Do you use a pump?  
a. Yes – what brand? __________ 
b. No 
8. Do you use a CGM/sensor? 
a. Yes – what brand? __________ 
b. No  
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Appendix C 
Daily Stress Survey  
Think about if each of these things has happened to you today. Select YES or NO for 
each item. For each item you say YES to, select how stressful it was for you today. For 











If you said YES: How stressful was this today? 
1 













as it can get 
 
 
    
If you said YES: How much was this event related to your diabetes? 
1 
Not at all  
2 


















If you said YES: How stressful was this today? 
1 













as it can get 
 
 
    
If you said YES: How much was this event related to your diabetes? 
1 
Not at all  
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If you said YES: How stressful was this today? 
1 













as it can get 
 
 
    
If you said YES: How much was this event related to your diabetes? 
1 
Not at all  
2 
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If you said YES: How stressful was this today? 
1 













as it can get 
 
 
    
If you said YES: How much was this event related to your diabetes? 
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Not at all  
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